CEO Interview

Trendlines Group, Ltd.  (OTC: TRNLY) Delivering 10X returns on Israeli medical and agricultural innovation

              Trendlines Group, Ltd.  (OTC: TRNLY) (Singapore: 42T), interview with co-CEO/Chairman Steve Rhodes, discussing the company’s investment strategy in early-stage medical and agricultural innovation companies in Israel and Singapore. Since […]

CEO Interview

BrainStorm Cell Therapeutics (NASDAQ: BCLI) Stem cell therapy for ALS in Phase III FDA trials

      BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) interview with CEO, Chaim Lebovits, discussing the company’s advancements in developing stem cell therapies to treat neurodegenerative diseases. The company’s pipeline includes a lead indication for ALS- Amyotrophic Lateral […]

CEO Interview

Pluristem Therapeutics, Inc. (NASDAQ: PSTI) Regenerative medicine technologies for billion dollar markets

            Pluristem Therapeutics, Inc. (NASDAQ: PSTI), interview with co-CEO Yaky Yanay. Yaky explains Pluristem’s regenerative medicine technologies, which use placenta-derived cell products, and address multi-billion health markets. Pluristem has 3 […]

CEO Interview

Elixinol Global Limited (OTC: ELLXF) Fast growing revenues in CBD & Hemp consumer products

[embedyt] https://www.youtube.com/watch?v=252QHfVcaoI[/embedyt] Elixinol Global Limited (ASX: EXL) (OTC: ELLXF) Interview with CEO, Paul Benhaim. We caught up with Paul, at the airport, to discuss Elixinol’s progress in the CBD and hemp consumer products and foods […]